Overview

Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The study involves the measurement of immune response to vaccination with three doses of a meningococcal B vaccine and a single dose of a meningococcal ACYW conjugate vaccine in healthy adults (Laboratory workers). The study will be completed at the Manchester Medical Microbiology Partnership in the UK and will enrol staff who may be at potential occupational exposure to meningococci. Blood samples will be taken before and after each vaccination and used to determine if the vaccines induce protective responses.
Phase:
Phase 2
Details
Lead Sponsor:
Dr. Elizabeth Miller
Prof. Elizabeth Miller
Collaborator:
Novartis Vaccines
Treatments:
Vaccines